Megumi Hamaguchi Selected Research

Megumi Hamaguchi Research Topics

7	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2022 - 06/2014
4	Neoplasms (Cancer) 01/2022 - 06/2014
4	Lung Neoplasms (Lung Cancer) 01/2022 - 11/2019
3	Adenocarcinoma 01/2022 - 04/2018
2	Fever (Fevers) 03/2022 - 01/2022
2	Pneumonia (Pneumonitis) 01/2022 - 07/2019
2	Interstitial Lung Diseases (Interstitial Lung Disease) 01/2022 - 01/2020
1	Rheumatoid Arthritis 03/2022
1	Necrosis 03/2022
1	Mycobacterium avium-intracellulare Infection 03/2022
1	Fatigue 03/2022
1	Airway Obstruction (Choking) 01/2022
1	Hypoxia (Hypoxemia) 01/2022
1	Chronic Obstructive Pulmonary Disease (COPD) 01/2022
1	Genetic Predisposition to Disease (Genetic Predisposition) 01/2022
1	Breast Neoplasms (Breast Cancer) 01/2022
1	Pathologic Constriction (Stenosis) 01/2022
1	Respiratory Insufficiency (Respiratory Failure) 01/2022
1	Malnutrition (Nutritional Deficiencies) 01/2021
1	Inflammation (Inflammations) 01/2021
1	Asthma (Bronchial Asthma) 01/2021
1	Granuloma 07/2019
1	Lymphoma (Lymphomas) 07/2019
1	Chickenpox 07/2019
1	Meningeal Carcinomatosis 03/2019
1	Adenocarcinoma of Lung 03/2019
1	Nausea 01/2019
1	Vomiting 01/2019
1	Erythema elevatum diutinum 04/2018
1	Graft vs Host Disease (Graft-Versus-Host Disease) 04/2018
1	Cysts 10/2016
1	Birt-Hogg-Dube Syndrome 10/2016

3	Biomarkers (Surrogate Marker)IBA 05/2021 - 06/2014
2	PlatinumIBA 05/2021 - 01/2021
2	ceritinibIBA 01/2020 - 04/2018
2	Anaplastic Lymphoma KinaseIBA 01/2020 - 03/2019
1	Immunosuppressive Agents (Immunosuppressants)IBA 03/2022
1	Etanercept (Enbrel)FDA Link 03/2022
1	Prothrombin (Factor II)IBA 01/2022
1	NivolumabIBA 01/2022
1	Ado-Trastuzumab EmtansineIBA 01/2022
1	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 01/2022
1	Antineoplastic Agents (Antineoplastics)IBA 01/2022
1	SmokeIBA 01/2022
1	Pharmaceutical PreparationsIBA 01/2022
1	Gefitinib (Iressa)FDA Link 10/2021
1	Erlotinib Hydrochloride (CP 358,774)FDA Link 10/2021
1	ErbB Receptors (EGF Receptor)IBA 10/2021
1	AntibodiesIBA 05/2021
1	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2021
1	Indicators and Reagents (Reagents)IBA 01/2021
1	Methylprednisolone FDA LinkGeneric 01/2020
1	Immunoglobulins (Immunoglobulin)IBA 07/2019
1	Prednisolone (Predate)FDA LinkGeneric 07/2019
1	Antiviral Agents (Antivirals)IBA 07/2019
1	Procarbazine (Matulane)FDA Link 07/2019
1	DNA (Deoxyribonucleic Acid)IBA 07/2019
1	Acyclovir (Aciclovir)FDA LinkGeneric 07/2019
1	CrizotinibIBA 03/2019
1	5-HT3 Serotonin Receptors (5 HT3 Receptor)IBA 01/2019
1	Proteins (Proteins, Gene)FDA Link 04/2018
1	Antigen-Antibody Complex (Immune Complex)IBA 04/2018
1	Cholinergic Antagonists (Anticholinergics)IBA 10/2016

3	Therapeutics 01/2022 - 07/2019
3	Drug Therapy (Chemotherapy) 05/2021 - 01/2019
1	Chemoradiotherapy 01/2022
1	Molecular Targeted Therapy 01/2022
1	Off-Label Use 01/2022
1	Stents 01/2022
1	Radiotherapy 01/2022
1	Drug Tapering 10/2021
1	Palliative Care (Palliative Therapy) 09/2021
1	Combination Drug Therapy (Combination Chemotherapy) 01/2021
1	COPP protocol 07/2019
1	Stem Cell Transplantation 04/2018